ForeseeHome
Monitoring for progression from intermediate dry AMD to wet AMD
ApprovedActive
Key Facts
Indication
Monitoring for progression from intermediate dry AMD to wet AMD
Phase
Approved
Status
Active
Company
About Notal Vision
Notal Vision is a commercial-stage digital health company focused on transforming the management of retinal diseases through home-based diagnostics and AI-enabled monitoring. Its flagship product, the ForeseeHome device, is Medicare-reimbursed and proven in a large NIH trial to help preserve vision by enabling earlier detection of wet AMD progression. The company is developing a pipeline that includes Home OCT and is building a centralized Monitoring Center service to connect patients and physicians with real-time data, aiming to shift treatment from a standardized schedule to an on-demand, activity-based regimen.
View full company profile